학술논문
Device-associated infection rates in Intensive Care Units of five cities of the Kingdom of Saudi Arabia: International Nosocomial Infection Control Consortium (INCC) findings.
Document Type
Academic Journal
Author
Al-Abdely, Hail M.; Alshehri, Areej Dhafer; Rosenthal, Victor Daniel; Banjar, Weam; Mohammed, Yassir Khidir; Assiri, Abdullah Mufareh; Fabros Cabato, Analen; Gonzales Celiz, Jerlie Mae; Al Raey, Mohammed Abdullah; Al Enizy, Hessa Abdullah; Abedel Kader, Nahla Moustafa; Mohammed, Diaa Abdullah; Al-Awadi, Duaa Khalil; Wasbourne, Maria; Saliya, Randa; Al-Zaydani Asiri, Ibrahim A. M.; Aldarani, Saeed Ali; Laungayan Cortez, Elizabeth; Demaisip, Nadia Lynette; Aziz, Misbah Rehman; et al
Source
Subject
Language
English
ISSN
1183-5702
Abstract
Background: This report summarizes the results of the International Nosocomial Infection Control Consortium (INICC) study conducted in five cities of the Kingdom of Saudi Arabia from September 2013 through March 2015. Methods: We utilized an online surveillance system in a prospective, cohort study of device-associated healthcare-associated infections (DA-HAI) in seven adult and pediatric intensive care units (ICUs) of five hospitals. The study applied CDC/NHSN criteria and definitions, using INICC Surveillance Online System. Results: Data was collected from 4,551 ICU patients for 30,041 bed-days. In the Medical/Surgical ICUs, the central-line associated bloodstream infection (CLABSI) rate was 4.5 per 1,000 central line (CL)-days; the ventilator-associated pneumonia (VAP) rate was 7.5 per 1,000 mechanical ventilator (MV)-days; and the catheter-associated urinary tract infection (CAUTI) rate was 4.7 per 1,000 urinary catheter (UC)-days. The rates were statistically significantly higher compared to CDC/NHSN rates (0.8 [CLABSI]; 1.1 [VAP]; and 1.3 [CAUTI]), whereas in comparison with INICC rates (4.9 [CLABSI]; 5.3 [CAUTI]; 16.5 [VAP]), CLABSI and CAUTI rates did not attain statistically significant difference and VAP rate was statistically significantly lower. With the exception of CL DUR in the pediatric ICUs, device utilization ratios were higher than INICC and CDC/NHSN's. Excess length of stay was 14.8 days for patients with CLABSI, 17.5 for patients with VAP and 22.1 for patients with CAUTI. Excess mortality was 38.4% for CLABSI, 31.8% for VAP and 19.0% for CAUTI in adult and pediatric ICUs. Conclusions: DA-HAI rates found in the study are higher than CDC/NSHN reported rates and similar to or lower than INICC's.